Academy of Medical Sciences of the I.R. of Iran, Tehran, Iran.
Arch Iran Med. 2011 Nov;14(6):425-30.
From ancient time leprosy has been regarded as a terrifying, stigmatized disease; nevertheless, its cause remained unidentified up to the late 19th century. For centuries numerous leprosy victims worldwide suffered from its morbidity and were socially isolated. The afflicted individuals were segregated because they were considered 'unclean' and had to live in leper colonies, generally under very poor conditions. Physicians believed that leprosy was an incurable, highly contagious, and hereditary disease. In 1873 the Norwegian physician, Gerhard Armauer Hansen (1841-1912), ended the myth of leprosy and discovered its causative agent, known as Mycobacterium leprae. Hansen's discovery was a great triumph in the fight against leprosy. In the 1930's, the first effective antileprosy drug, dapsone, was introduced and in the early 1980's multi-drug therapy was popularized because of high efficacy in resistant cases. Here, we have presented a brief look at the history of leprosy in the world with special focus on the historical account of leprosy in Iran, particularly during the 19th and 20th centuries.
从古至今,麻风病一直被视为一种可怕的、带有耻辱性的疾病;尽管如此,直到 19 世纪末期,其病因仍未被查明。几个世纪以来,全世界有许多麻风病患者深受其病痛折磨,并被社会隔离。患病者被隔离,因为他们被认为是“不洁净的”,必须生活在麻风病隔离区,通常生活条件非常恶劣。医生认为麻风病是一种无法治愈、高度传染性且遗传性的疾病。1873 年,挪威医生 Gerhard Armauer Hansen(1841-1912)终结了麻风病的神话,并发现了其病原体,即麻风分枝杆菌。Hansen 的发现是对抗麻风病的巨大胜利。20 世纪 30 年代,第一种有效的抗麻风病药物氨苯砜问世,80 年代初,由于在耐药病例中具有较高的疗效,多药疗法得到了普及。在这里,我们简要回顾了世界麻风病的历史,特别关注了 19 世纪和 20 世纪伊朗麻风病的历史记载。